Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 394

1.

Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.

Ulaner GA, Vu TH, Li T, Hu JF, Yao XM, Yang Y, Gorlick R, Meyers P, Healey J, Ladanyi M, Hoffman AR.

Hum Mol Genet. 2003 Mar 1;12(5):535-49.

PMID:
12588801
2.

Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.

Yang Y, Hu JF, Ulaner GA, Li T, Yao X, Vu TH, Hoffman AR.

J Cell Biochem. 2003 Dec 1;90(5):1038-55.

PMID:
14624463
3.

CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.

Ulaner GA, Yang Y, Hu JF, Li T, Vu TH, Hoffman AR.

Endocrinology. 2003 Oct;144(10):4420-6. Epub 2003 Jul 10.

PMID:
12960026
4.

Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer.

Takai D, Gonzales FA, Tsai YC, Thayer MJ, Jones PA.

Hum Mol Genet. 2001 Nov 1;10(23):2619-26.

PMID:
11726548
5.

A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells.

Fu VX, Schwarze SR, Kenowski ML, Leblanc S, Svaren J, Jarrard DF.

J Biol Chem. 2004 Dec 10;279(50):52218-26. Epub 2004 Oct 7.

6.
7.

Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.

Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, Nichols TD, Marks JR, Berchuck A.

Mol Cancer Res. 2006 Apr;4(4):283-92.

8.

Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance.

Pant V, Kurukuti S, Pugacheva E, Shamsuddin S, Mariano P, Renkawitz R, Klenova E, Lobanenkov V, Ohlsson R.

Mol Cell Biol. 2004 Apr;24(8):3497-504.

9.

IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.

Li T, Vu TH, Ulaner GA, Littman E, Ling JQ, Chen HL, Hu JF, Behr B, Giudice L, Hoffman AR.

Mol Hum Reprod. 2005 Sep;11(9):631-40. Epub 2005 Oct 11.

PMID:
16219628
10.
11.

Relationship of porcine IGF2 imprinting status to DNA methylation at the H19 DMD and the IGF2 DMRs 1 and 2.

Braunschweig MH, Owczarek-Lipska M, Stahlberger-Saitbekova N.

BMC Genet. 2011 May 17;12:47. doi: 10.1186/1471-2156-12-47.

12.

CTCF binding sites promote transcription initiation and prevent DNA methylation on the maternal allele at the imprinted H19/Igf2 locus.

Engel N, Thorvaldsen JL, Bartolomei MS.

Hum Mol Genet. 2006 Oct 1;15(19):2945-54. Epub 2006 Aug 23.

PMID:
16928784
13.

Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene.

Bell AC, Felsenfeld G.

Nature. 2000 May 25;405(6785):482-5.

PMID:
10839546
15.

CTCF maintains differential methylation at the Igf2/H19 locus.

Schoenherr CJ, Levorse JM, Tilghman SM.

Nat Genet. 2003 Jan;33(1):66-9. Epub 2002 Dec 2.

PMID:
12461525
16.
17.

Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.

Joyce JA, Lam WK, Catchpoole DJ, Jenks P, Reik W, Maher ER, Schofield PN.

Hum Mol Genet. 1997 Sep;6(9):1543-8.

PMID:
9285792
18.

Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.

Vu TH, Li T, Nguyen D, Nguyen BT, Yao XM, Hu JF, Hoffman AR.

Genomics. 2000 Mar 1;64(2):132-43.

PMID:
10729220
19.

Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.

Cui H, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, Lobanenkov VV, Feinberg AP.

Cancer Res. 2001 Jul 1;61(13):4947-50.

20.

Methylation status of imprinting centers for H19/IGF2 and SNURF/SNRPN in primate embryonic stem cells.

Mitalipov S, Clepper L, Sritanaudomchai H, Fujimoto A, Wolf D.

Stem Cells. 2007 Mar;25(3):581-8. Epub 2006 Dec 14.

Supplemental Content

Support Center